EC
OGN icon

EntryPoint Capital’s Organon & Co OGN Stock Holding History

EntryPoint Capital’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,231
Closed -$91.2K – 910
2026
Q1 		$91.2K Hold
15,231
– – 0.03% 710
2025
Q4 		$109K Buy
15,231
+3,310
+28% +$26.2K 0.04% 606
2025
Q3 		$127K Buy
11,921
+926
+8% +$9.09K 0.05% 607
2025
Q2 		$106K Sell
10,995
-397
-3% -$4.09K 0.05% 561
2025
Q1 		$170K Sell
11,392
-16,547
-59% -$254K 0.08% 570
2024
Q4 		$417K Buy
+27,939
New +$455K 0.18% 190

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

EntryPoint Capital's OGN Position: Q2 2026 in Review

EntryPoint Capital sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 15,231 shares — an estimated $91.2K sold.

EntryPoint Capital first reported a position in OGN in Q4 2024 and held it in 6 quarters. The position peaked at $417K in Q4 2024. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • EntryPoint Capital reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • EntryPoint Capital sold 15,231 Organon & Co shares in Q2 2026, an estimated $91.2K.
  • EntryPoint Capital first reported a position in Organon & Co in Q4 2024 and held it in 6 quarters.
  • EntryPoint Capital's Organon & Co position peaked at $417K in Q4 2024.
  • 633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.